All Articles

Artificial intelligence is accelerating software development, but new data reveals it is simultaneously widening a critical digital accessibility gap.

Matt Gibson's transition from Goldman Sachs to Strategic Value Partners isn't just a corporate reshuffle—it's a window into the physical systems powering our digital age.

A new transpacific partnership between Cellares and GenomeFrontier signals a critical shift in cell therapy, swapping viral vectors for automated precision.

Stronghold's SHx token just cleared one of the world's highest regulatory bars. Here is why the BitTrade listing signals a major shift in APAC fintech.

As auto repair times surge and AI takes over claims, NJM Insurance proves that blending digital efficiency with human empathy is the ultimate strategy for 2026.

As pay transparency laws expand across 18 jurisdictions, HR leaders must fundamentally rethink compensation strategies to survive this new regulatory era.

A $2.5M Canadian class action settlement exposes the hidden costs of a global auto parts cartel, revealing how supply chain oligopolies inflate vehicle prices.

Digital therapeutics 1.0 crashed and burned. By fusing software directly with standard prescriptions, a new hybrid model is rewriting the pharma playbook.

A Dutch AI firm is planting its flag in San Francisco, betting it can automate not just Google search, but the new world of AI-driven answer engines.

With 60% of adults fearing natural disasters but only 15% prepared, a new Verizon and United Way initiative tackles the steep economic barriers to survival.

Triton Uranium claims a massive 46.56-million-pound target in Saskatchewan. But can a low-grade, open-pit play truly fuel the AI-driven nuclear renaissance?

Chemify secures £22M in grants and extends its Series B to £51.9M to build automated 'Chemifarms,' transforming chemical synthesis into executable code.

As autonomous AI agents breach corporate walls, a new cybersecurity arms race is on. An inside look at the battle to control the new, non-human identities.

IASO208’s FDA clearance marks a critical leap for in vivo CAR-T therapy, promising to strip away manufacturing bottlenecks and reshape global biopharma.

Binance opens its professional trading strategy marketplace, Capital Connect, to high-net-worth individuals, bridging the TradFi and crypto wealth gap.

Western enterprises are flocking to cheap Chinese AI models. But a new benchmark reveals they are unknowingly importing deep-seated political bias.

Bruynzeel Storage Systems taps Finnish family enterprise Laaksonen in an exclusive distribution pact, accelerating its push into Northern Europe's institutional infrastructure market.

ANCEL is using customer data to champion supercapacitor starters, a technology that tackles the root causes of dead batteries in cars, trucks, and more.

A novel non-viral gene therapy shows early promise in treating Geographic Atrophy, targeting the root cause of iron overload to potentially reverse vision loss.

While mega-mergers grab headlines, new research reveals that organic international expansion creates a far heavier operational burden for global businesses.